|Articles|November 22, 2017

Flu Shot in Children Can Reduce Risk of Infection-Related Hospitalization

Author(s)Einav Keet

With news of a Las Vegas-area child’s flu-related death, a new study finds that kids who receive the flu shot have a much lower risk of being hospitalized for the illness.

As Southern Nevada reports its first pediatric influenza death of the 2017-2018 flu season, a new study out of Canada has found that children who receive the flu vaccine are far less likely to be hospitalized with the virus.

For Week 45 ending November 11, 2017, the Centers for Disease Control and Prevention (CDC) reported an increase in flu activity since the prior week. The weekly FluView report notes that 9 states —Arkansas, California, Georgia, Louisiana, Massachusetts, Mississippi, Oklahoma, South Carolina, and Washington – along with Guam and Puerto Rico, reported regional influenza activity, which is up from 6 states and Guam the prior week. No pediatric flu deaths were reported as of Week 45. Since the 2004-2005 flu season, the United States has seen 37 to as many as 171 flu-related pediatric deaths each season.

On November 20th, the Southern Nevada Health District (SNHD) reported the first pediatric flu death of the 2017-2018 season in Clark County, releasing only that the death occurred in a child in the 0-4 age group. Health officials with SNHD say that they’ve seen 78 confirmed flu cases as of November 11th and that 43% of those recently visiting the emergency department for influenza-like illness were children in the 0-4 age group. The CDC notes that children younger than 5 years are at higher risk for developing serious complications due to the flu. “A flu-related death is a tragic reminder that influenza can be a serious illness,” said SNHD chief health officer Joe Iser, MD, in a recent statement. “Young children, older adults, and people with certain health conditions may be more at risk for complications. With the holiday season approaching, we want to remind everyone to get a flu shot, and to practice healthy habits to protect yourself and your family.”

A study released earlier this year by the CDC found that flu vaccination cuts a child’s risk of dying from influenza in half for children with underlying health conditions, and by almost two-thirds for healthy children. Now, in a new study published in the journal PLOS One, researchers from Public Health Ontario and the Institute for Clinical Evaluative Sciences in Toronto have found that children who receive the seasonal flu shot experience a lower risk of hospitalization from serious complications from the illness. The study looked at specimens collected from 9,982 patient hospitalizations among children 6 to 59 months, from the 2010-2011 flu season through the 2013-2014 flu season. During the study period, 12.8% of specimens tested positive for influenza.

Over the course of the 4 flu seasons, children who were fully vaccinated against the flu saw a 60% drop in their risk for hospitalization due to the virus, while children who had received just one dose of the vaccine in their first flu season had a 39% drop in hospitalization risk. The highest rate of protection occurred in fully vaccinated children aged 24 to 59 months, who had a 67% reduction in risk of flu hospitalization. “Influenza can cause serious illness, especially in young children, but there hasn’t been a lot of research that has examined the magnitude of the influenza vaccine’s effectiveness at preventing kids from getting really sick and being hospitalized,” says senior author Jeff Kwong, MD, in a recent PHO press release. “This research paper helps fill that gap by showing how effective the influenza vaccine can be at protecting young kids against serious complications from influenza infections.”

The CDC recommends the flu vaccine for all healthy children aged 6 months and older, emphasizing that children younger than 5 years — particularly those younger than 2 years – are at higher risk of serious influenza complications.


Related to this article

NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.